Novartis Korea appoints Byungjae Yoo as new head
By Eo, Yun-Ho | translator Alice Kang
21.09.15 06:20:00
가나다라
0
Byungjae Yoo, who will officially be appointed in October, is the second Korean head to be appointed since 2015
Expectation rise that his appointment will bring synergy into reimbursement discussions for the company’s high-priced new drugs, such as Zolgensma and Kymriah
▲Byungjae Yoo, new General Manger of Novartis Korea
Byungjae Yoo, the former Managing Director of Johnson & Johnson Medical North Asia, has been appointed as the new head to lead Novartis Korea.The company had recently announced through an internal notice that Yoo will be officially appointed as its General Manager from October 1st.
This will be the second time since the company's establishment that the Korean subsidiary will be managed by a Korean leader.
After completing his MBA at Harvard Business School, the newly appointed General Manager Yoo had joined J&J in 2006 through the company’s International Recruitment & Development Program.
Since then, Yoo had held various roles in the company, including on
Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)